|
1
|
Pourhanifeh MH, Darvish M, Tabatabaeian J,
Fard MR, Mottaghi R, Azadchehr MJ, Jahanshahi M, Sahebkar A and
Mirzaei H: Therapeutic role of curcumin and its novel formulations
in gynecological cancers. J Ovarian Res. 13:1302020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nahand JS, Vandchali NR, Darabi H,
Doroudian M, Banafshe HR, Moghoofei M, Babaei F, Salmaninejad A and
Mirzaei H: Exosomal microRNAs: Novel players in cervical cancer.
Epigenomics. 12:1651–1660. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sadri Nahand J, Moghoofei M, Salmaninejad
A, Bahmanpour Z, Karimzadeh M, Nasiri M, Mirzaei HR, Pourhanifeh
MH, Bokharaei-Salim F, Mirzaei H, et al: Pathogenic role of
exosomes and microRNAs in HPV-mediated inflammation and cervical
cancer: A review. Int J Cancer. 146:305–320. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yu F, Liu J, Dong W, Xie J and Zhao X: The
diagnostic value of miR-145 and miR-205 in patients with cervical
cancer. Am J Transl Res. 13:1825–1832. 2021.PubMed/NCBI
|
|
5
|
Yang PM, Chou CJ, Tseng SH and Hung CF:
Bioinformatics and in vitro experimental analyses identify the
selective therapeutic potential of interferon gamma and apigenin
against cervical squamous cell carcinoma and adenocarcinoma.
Oncotarget. 8:46145–46162. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Park S, Eom K, Kim J, Bang H, Wang HY, Ahn
S, Kim G, Jang H, Kim S, Lee D, et al: MiR-9, miR-21, and miR-155
as potential biomarkers for HPV positive and negative cervical
cancer. BMC Cancer. 17:6582017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Causin RL, da Silva LS, Evangelista AF,
Leal LF, Souza KC, Pessôa-Pereira D, Matsushita GM, Reis RM,
Fregnani JH and Marques MM: MicroRNA biomarkers of high-grade
cervical intraepithelial neoplasia in liquid biopsy. BioMed Res
Int. 2021:66509662021. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Boscolo-Rizzo P, Furlan C, Lupato V,
Polesel J and Fratta E: Novel insights into epigenetic drivers of
oropharyngeal squamous cell carcinoma: Role of HPV and lifestyle
factors. Clin Epigenetics. 9:1242017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zamani S, Sohrabi A, Hosseini SM,
Rahnamaye-Farzami M and Akbari A: Deregulation of miR-21 and
miR-29a in Cervical Cancer Related to HPV Infection. MicroRNA.
8:110–115. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li J, Chu ZP, Han H, Zhang Y, Tian F,
Zhang JQ and Huang XH: Suppression of miR-93-5p inhibits high-risk
HPV-positive cervical cancer progression via targeting of BTG3. Hum
Cell. 32:160–171. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nohata N, Abba MC and Gutkind JS:
Unraveling the oral cancer lncRNAome: Identification of novel
lncRNAs associated with malignant progression and HPV infection.
Oral Oncol. 59:58–66. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Razavi ZS, Asgarpour K, Mahjoubin-Tehran
M, Rasouli S, Khan H, Shahrzad MK, Hamblin MR and Mirzaei H:
Angiogenesis-related non-coding RNAs and gastrointestinal cancer.
Mol Ther Oncolytics. 21:220–241. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mahjoubin-Tehran M, Rezaei S, Jesmani A,
Birang N, Morshedi K, Khanbabaei H, Khan H, Piranviseh A, Nejati M,
Aschner M, et al: New epigenetic players in stroke pathogenesis:
From non-coding RNAs to exosomal non-coding RNAs. Biomed
Pharmacother. 140:1117532021. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shafabakhsh R, Arianfar F, Vosough M,
Mirzaei HR, Mahjoubin-Tehran M, Khanbabaei H, Kowsari H, Shojaie L,
Azar ME, Hamblin MR, et al: Autophagy and gastrointestinal cancers:
The behind the scenes role of long non-coding RNAs in initiation,
progression, and treatment resistance. Cancer Gene Ther. Jan
11–2021.(Epub ahead of print). doi: 10.1038/s41417-020-00272-7.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mirzaei H and Hamblin MR: Regulation of
glycolysis by non-coding RNAs in cancer: Switching on the Warburg
effect. Mol Ther Oncolytics. 19:218–239. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hashemian SM, Pourhanifeh MH, Fadaei S,
Velayati AA, Mirzaei H and Hamblin MR: Non-coding RNAs and
exosomes: their role in the pathogenesis of sepsis. Mol Ther
Nucleic Acids. 21:51–74. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hashemipour M, Boroumand H, Mollazadeh S,
Tajiknia V, Nourollahzadeh Z, Rohani Borj M, Pourghadamyari H,
Rahimian N, Hamblin MR and Mirzaei H: Exosomal microRNAs and
exosomal long non-coding RNAs in gynecologic cancers. Gynecol
Oncol. 161:314–327. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rahimian N, Razavi ZS, Aslanbeigi F,
Mirkhabbaz AM, Piroozmand H, Shahrzad MK, Hamblin MR and Mirzaei H:
Non-coding RNAs related to angiogenesis in gynecological cancer.
Gynecol Oncol. 161:896–912. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Razavi ZS, Tajiknia V, Majidi S, Ghandali
M, Mirzaei HR, Rahimian N, Hamblin MR and Mirzaei H: Gynecologic
cancers and non-coding RNAs: Epigenetic regulators with emerging
roles. Crit Rev Oncol Hematol. 157:1031922021. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu C, Tian X, Zhang J and Jiang L: Long
Non-coding RNA DLEU1 promotes proliferation and invasion by
interacting with miR-381 and enhancing HOXA13 expression in
cervical cancer. Front Genet. 9:6292018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lv QL, Wang LC, Li DC, Lin QX, Shen XL,
Liu HY, Li M, Ji YL, Qin CZ and Chen SH: Knockdown lncRNA DLEU1
inhibits gliomas progression and promotes temozolomide
chemosensitivity by regulating autophagy. Front Pharmacol.
11:5605432020. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shan L, Zhao T and Wang Y: Upregulation of
Serum lncRNA DLEU1 predicts progression of premalignant endometrial
lesion and unfavorable clinical outcome of endometrial cancer.
Technol Cancer Res Treat. Dec 17–2020.(Epub ahead of print). doi:
10.1177/1533033820965589. View Article : Google Scholar
|
|
24
|
Lv T, Liu H, Wu Y and Huang W: Knockdown
of lncRNA DLEU1 inhibits the tumorigenesis of oral squamous cell
carcinoma via regulation of miR-149 5p/CDK6 axis. Mol Med Rep.
23:4472021. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kopczyńska M, Kolenda T, Guglas K,
Sobocińska J, Teresiak A, Bliźniak R, Mackiewicz A, Mackiewicz J
and Lamperska K: PRINS lncRNA is a new biomarker candidate for HPV
infection and prognosis of head and neck squamous cell carcinomas.
Diagnostics (Basel). 10:E7622020. View Article : Google Scholar
|
|
26
|
Zhou D, Wu F, Cui Y, Wei F, Meng Q and Lv
Q: Long non-coding RNA-OIS1 inhibits HPV-positive, but not
HPV-negative cervical squamous cell carcinoma by upregulating
MTK-1. Oncol Lett. 17:2923–2930. 2019.PubMed/NCBI
|
|
27
|
Zhang Y, Jia LG, Wang P, Li J, Tian F, Chu
ZP and Kang S: The expression and significance of lncRNA HOST2 and
microRNA let-7b in HPV-positive cervical cancer tissues and cell
lines. Eur Rev Med Pharmacol Sci. 23:2380–2390. 2019.PubMed/NCBI
|
|
28
|
Iancu IV, Anton G, Botezatu A, Huica I,
Nastase A, Socolov DG, Stanescu AD, Dima SO, Bacalbasa N and Plesa
A: LINC01101 and LINC00277 expression levels as novel factors in
HPV-induced cervical neoplasia. J Cell Mol Med. 21:3787–3794. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fattahi S, Nikbakhsh N, Taheri H, Ghadami
E, Ranaee M and Akhavan-Niaki H: LINC02688 and PP7080 as novel
biomarkers in early diagnosis of gastric cancer. Noncoding RNA Res.
6:86–91. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang Y, Sun Y, Ding L, Shi W, Ding K and
Zhu Y: Long non-coding RNA LINC00467 correlates to poor prognosis
and aggressiveness of breast cancer. Front Oncol. 11:6433942021.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chao Y and Zhou D: lncRNA-D16366 is a
potential biomarker for diagnosis and prognosis of hepatocellular
carcinoma. Med Sci Monit. 25:6581–6586. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Du P, Zhi Y, Wang R, Li Y, Li H, Zhang X,
Cheng G and Li X: Aberrant methylation of the SOX21-AS1 promoter
region promotes gene expression and its clinical value in cervical
cancer. Reprod Sci. 28:532–540. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang J, Jiang P, Wang S, Cheng W and Fu
S: LncRNA LIPE-AS1 predicts poor survival of cervical cancer and
promotes its proliferation and migration via modulating
miR-195-5p/MAPK pathway. Front Oncol. 11:6399802021. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang J, Zhang Y, Lin R, Mao B, Wang W, Bai
Y, He W and Liu Q: Long noncoding RNA loc285194 expression in human
papillomavirus-positive and -negative cervical squamous cell
carcinoma, C33A, and SiHa cells and transforming growth factor-β1.
Med Sci Monit. 25:9012–9018. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jin L, Ji J, Shi L, Jin S and Pei L:
lncRNA HAND2-AS1 inhibits cancer cell proliferation, migration and
invasion by downregulating ROCK1 in HPV-positive and negative
cervical squamous cell carcinoma. Exp Ther Med. 18:2512–2518.
2019.PubMed/NCBI
|
|
36
|
Liu Y, Li M, Yu H and Piao H: LncRNA SRA1
is down-regulated in HPV-negative cervical squamous cell carcinoma
and regulates cancer cell behaviors. Biosci Rep. Aug 15–2019.(Epub
ahead of print). doi: 10.1042/BSR20191226.
|
|
37
|
Cao Y, Yang R, Lee I, Zhang W, Sun J, Meng
X and Wang W: Prediction of LncRNA-encoded small peptides in glioma
and oligomer channel functional analysis using in silico
approaches. PLoS One. 16:e02486342021. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang C, Xie XX, Li WJ and Jiang DQ: LncRNA
DLEU1/microRNA-300/RAB22A axis regulates migration and invasion of
breast cancer cells. Eur Rev Med Pharmacol Sci. 23:10410–10421.
2019.PubMed/NCBI
|
|
39
|
Zhang X, Wang Y, Zhao A, Kong F, Jiang L
and Wang J: Long Non-coding RNA LINC00511 accelerates proliferation
and invasion in cervical cancer through targeting miR-324-5p/DRAM1
axis. OncoTargets Ther. 13:10245–10256. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Liu S, Song L, Zeng S and Zhang L:
MALAT1-miR-124-RBG2 axis is involved in growth and invasion of
HR-HPV-positive cervical cancer cells. Tumour Biol. 37:633–640.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Jiang S, Qi Y, He R, Huang Y, Liu Z, Ma Y,
Guo X, Shao Y, Sun Z and Ruan Q: Human cytomegalovirus microRNA
miR-US25-1-5p inhibits viral replication by targeting multiple
cellular genes during infection. Gene. 570:108–114. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Broccolo F, Cassina G, Chiari S,
Garcia-Parra R, Villa A, Leone BE, Brenna A, Locatelli G, Mangioni
C and Cocuzza CE: Frequency and clinical significance of human
beta-herpesviruses in cervical samples from Italian women. J Med
Virol. 80:147–153. 2008. View Article : Google Scholar : PubMed/NCBI
|
